ADVERTISEMENT

Galaxy Surfactants Gets 'Add' As Yes Securities Initiates Coverage, Sees 16% Upside

The company is almost debt-free, leading to negligible interest burden, adds the brokerage.

<div class="paragraphs"><p>Galaxy Surfactants relentless focus on expanding the high-margin specialty care product segment, currently fetching ~40% of revenues, is expected to drive an Ebitda CAGR of ~14.3% over the span FY24-27.</p><p></p><p>Beakers containing beer sit on a table in a laboratory. (Photo: Dragos Condrea/ freepik)</p></div>
Galaxy Surfactants relentless focus on expanding the high-margin specialty care product segment, currently fetching ~40% of revenues, is expected to drive an Ebitda CAGR of ~14.3% over the span FY24-27.

Beakers containing beer sit on a table in a laboratory. (Photo: Dragos Condrea/ freepik)

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit